Sat, Dec 20, 2014, 6:57 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Endocyte, Inc. (ECYT) Message Board

  • justarook04 justarook04 Jun 17, 2014 4:16 PM Flag

    So the market valued Merck's part in this at 20%?

    Way overreaction. Merck just spent $3.85B on IDIX which could be a "crapshoot". They were after the Ovarian cancer windfall and that is now gone. The lung disease market is much bigger. Anyway, today's surge should have had NOTHING to do with Merck and everything to do about the Phase IIB Lung trial. Now foolish panic has set in (again). We shall see if the Analysts chime in.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.24-0.10(-1.50%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.